Table 2. Summary of the 29 cases with regional lymph node metastasis and/or postoperative recurrence of endometrial endometrioid carcinoma.
No. | FIGO stage | Grade | MI | LVSI | Lymph node dissection | Metastatic lymph node in surgery | Postoperative metastasis |
---|---|---|---|---|---|---|---|
1 | IA | G1 | <1/2 | + | Pelvic LN | No | PAN |
2 | IA | G2 | < | + | Pelvic LN | No | Liver, Cardiophrenic LN |
3 | IA | G2 | < | - | Pelvic LN | No | PAN |
4 | IA | G2 | < | - | Pelvic LN | No | PAN, Peritoneum, Omentum |
5 | IA | G2 | < | - | Pelvic LN | No | Pelvic LN |
6 | IA | G3 | < | + | Pelvic LN | No | PAN, Lung |
7 | IA | G3 | < | + | Pelvic LN | No | Lung, Bone, Mediastinal LN |
8 | IB | G1 | ≥ | + | Pelvic LN | No | Lung |
9 | IB | G1 | ≥ | + | Pelvic LN | No | PAN |
10 | IB | G2 | ≥ | + | No | No | PAN |
11 | IB | G2 | ≥ | + | No | No | Pelvic LN, Lung |
12 | IB | G2 | ≥ | + | No | No | PAN |
13 | IB | G3 | ≥ | + | Pelvic LN | No | PAN |
14 | II | G1 | ≥ | + | Pelvic LN | No | Lung |
15 | II | G1 | ≥ | - | Pelvic LN | No | Pelvic LN |
16 | IIIA | G2 | ≥ | + | No | No | PAN |
17 | IIIA | G3 | ≥ | + | Pelvic LN | No | Pelvic LN |
18 | IIIC | G1 | < | - | Pelvic LN | Pelvic LN | PAN |
19 | IIIC | G1 | ≥ | + | Pelvic LN | Pelvic LN | No |
20 | IIIC | G1 | ≥ | + | Pelvic LN | Pelvic LN | PAN |
21 | IIIC | G2 | < | - | Pelvic LN | Pelvic LN | Lung |
22 | IIIC | G2 | ≥ | + | Pelvic LN | Pelvic LN | No |
23 | IIIC | G2 | ≥ | + | Pelvic LN-PAN | Pelvic LN | Lung |
24 | IIIC | G3 | ≥ | + | Pelvic LN-PAN | Pelvic LN | Lung, Peritoneum |
25 | IIIC | G3 | ≥ | + | Pelvic LN | Pelvic LN | No |
26 | IIIC | G3 | ≥ | + | Pelvic LN-PAN | Pelvic LN | Peritoneum |
27 | IIIC | G3 | ≥ | + | Pelvic LN-PAN | Pelvic LN, PAN | Bone, Lung, Peritoneum |
28 | IIIC | G3 | ≥ | + | Pelvic LN | Pelvic LN | Peritoneum |
29 | IIIC | G3 | ≥ | + | Pelvic LN | Pelvic LN | No |
MI, muscular invasion; LVSI, lymph-vascular space invasion; LN, lymph node; PAN, para-aortic lymph node.